Minireviews
World J Diabetes
8(3):89-96.
Published online Mar 15, 2017.
doi: 10.4239/wjd.v8.i3.89
Abstract (1164)
|
Core Tip (830)
|
Full Article (HTML) (5879)
|
Tables (1-3) (165)
|
Full Article (PDF)-2663K (1052)
|
Audio-337K (20)
|
Peer-Review Report-80K (202)
|
Answering Reviewers-218K (216)
|
Received: 08/27/2016
|
Revised: 11/30/2016
|
Accepted: 12/28/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (13538)
|
Similar Articles (181)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Diabetes
8(3):97-103.
Published online Mar 15, 2017.
doi: 10.4239/wjd.v8.i3.97
Abstract (967)
|
Core Tip (792)
|
Full Article (HTML) (4760)
|
Figures (1-3) (212)
|
Tables (1-1) (158)
|
Full Article (PDF)-1468K (534)
|
Audio-1514K (25)
|
Peer-Review Report-125K (240)
|
Answering Reviewers-193K (164)
|
Received: 03/25/2016
|
Revised: 08/31/2016
|
Accepted: 01/14/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (14497)
|
Similar Articles (99)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes
World J Diabetes
8(3):104-111.
Published online Mar 15, 2017.
doi: 10.4239/wjd.v8.i3.104
Abstract (1100)
|
Core Tip (865)
|
Full Article (HTML) (3772)
|
Figures (1-3) (156)
|
Tables (1-2) (150)
|
Full Article (PDF)-2131K (521)
|
Audio-2694K (27)
|
Peer-Review Report-124K (251)
|
Answering Reviewers-221K (356)
|
Received: 10/27/2016
|
Revised: 12/14/2016
|
Accepted: 01/03/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (35)
|
Total Visits (15499)
|
Similar Articles (99)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Prospective Study
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
World J Diabetes
8(3):112-119.
Published online Mar 15, 2017.
doi: 10.4239/wjd.v8.i3.112
Abstract (988)
|
Core Tip (1002)
|
Full Article (HTML) (3640)
|
Tables (1-6) (165)
|
Full Article (PDF)-1041K (511)
|
Audio-2384K (29)
|
Peer-Review Report-117K (319)
|
Answering Reviewers-160K (208)
|
Received: 07/10/2016
|
Revised: 09/26/2016
|
Accepted: 11/22/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (16548)
|
Similar Articles (25)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open